CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
FMT Capsules +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02530385
NCT02530385Phase 2Completed
CompareCT.gov

Placebo Controlled Study of Fecal Microbiota Transplant (FMT) to Impact Body Weight and Glycemic Control in Adults Using a Frozen Encapsulated Inoculum

Massachusetts General Hospital·interventional·Posted Aug 21, 2015·Updated Jul 25, 2019

In Brief

A Phase 2 clinical trial evaluating Placebo Capsules and FMT Capsules for Obesity. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of this study is to study the impact of gut bacteria on weight. Fecal microbiota transplantation (FMT) transfers intestinal bacteria by a "stool transplant" from a healthy, lean person to a person with obesity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 21, 2015
Enrollment StartJun 1, 2016
Primary CompletionJun 27, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 10.9 years ago

Interventions

Placebo Capsulesother

Placebo capsules contain powdered cocoa and gelatin

FMT Capsulesbiological

Capsules will be generated as per FDA-approved procedures